Santa Cruz Biotechnology
Private Company
Funding information not available
Overview
Santa Cruz Biotechnology is a well-established, privately-held provider of critical research tools for the global biomedical research community. The company has built a strong reputation over three decades as a key supplier of antibodies, gene silencing/editing technologies, and basic lab supplies. While its core business is research reagents, it has diversified into animal health through its 'Santa Cruz Animal Health' division. Its extensive product catalog and high citation count underscore its entrenched position in the academic and industrial research markets.
Technology Platform
Integrated provider of research reagents including antibody production, RNAi gene silencing tools, CRISPR/Cas9 gene editing plasmids, and laboratory chemicals/supplies.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Operates in the highly fragmented and competitive life science reagents market. Competes with global giants like Thermo Fisher Scientific, Abcam, and Merck Millipore on breadth, price, and quality, and with numerous specialized antibody startups on innovation and validation. Its diversification into gene editing tools pits it against dedicated CRISPR companies as well.